Steven Cohen's PACB Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 285,700 shares of Pacific Biosciences of California, Inc. (PACB) worth $377,124, representing 0.00% of the portfolio. First purchased in 2015-Q2, this long-term strategic position has been held for 25 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in PACB, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 2.96 M shares. Largest reduction occurred in Q1 2024, reducing 5.35 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Pacific Biosciences of California (PACB) Holding Value Over Time
Track share changes against reported price movement
Quarterly Pacific Biosciences of California (PACB) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -2.67 M | Reduce 90.34% | 285,700 | $1.32 |
| Q4 2025 | +2.96 M | New Buy | 2.96 M | $1.87 |
| Q3 2025 | -914,190 | Sold Out | 0 | $0.00 |
| Q2 2025 | +914,190 | New Buy | 914,190 | $1.24 |
| Q1 2024 | -5.35 M | Sold Out | 0 | $0.00 |
| Q4 2023 | +2.76 M | Add 106.23% | 5.35 M | $9.81 |
| Q3 2023 | -4.07 M | Reduce 61.06% | 2.59 M | $8.35 |
| Q2 2023 | -627,735 | Reduce 8.61% | 6.66 M | $13.30 |
| Q1 2023 | +1.96 M | Add 36.71% | 7.29 M | $11.58 |
| Q4 2022 | +2.8 M | Add 110.41% | 5.33 M | $8.18 |
| Q3 2022 | +2.53 M | New Buy | 2.53 M | $5.80 |
| Q1 2021 | -40,000 | Sold Out | 0 | $0.00 |
| Q4 2020 | -2.27 M | Reduce 98.27% | 40,000 | $25.95 |
| Q3 2020 | +2.31 M | New Buy | 2.31 M | $9.87 |
| Q4 2018 | -5.18 M | Sold Out | 0 | $0.00 |
| Q3 2018 | +2.28 M | Add 78.45% | 5.18 M | $5.41 |
| Q2 2018 | +800,000 | Add 38.10% | 2.9 M | $3.55 |
| Q1 2018 | +2.1 M | New Buy | 2.1 M | $2.05 |
| Q2 2017 | -1.28 M | Sold Out | 0 | $0.00 |
| Q1 2017 | +1.28 M | New Buy | 1.28 M | $5.17 |
| Q2 2016 | -706,500 | Sold Out | 0 | $0.00 |
| Q1 2016 | +700,300 | Add 11295.16% | 706,500 | $8.50 |
| Q4 2015 | -10,900 | Reduce 63.74% | 6,200 | $13.06 |
| Q3 2015 | +17,000 | Add 17000.00% | 17,100 | $3.68 |
| Q2 2015 | +100 | New Buy | 100 | $10.00 |
Steven Cohen's Pacific Biosciences of California Investment FAQs
Steven Cohen first purchased Pacific Biosciences of California, Inc. (PACB) in Q2 2015, acquiring 100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Pacific Biosciences of California, Inc. (PACB) for 25 quarters since Q2 2015.
Steven Cohen's largest addition to Pacific Biosciences of California, Inc. (PACB) was in Q4 2025, adding 2,957,400 shares worth $5.53 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 285,700 shares of Pacific Biosciences of California, Inc. (PACB), valued at approximately $377,124.
As of the Q1 2026 filing, Pacific Biosciences of California, Inc. (PACB) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Pacific Biosciences of California, Inc. (PACB) was 7,289,368 shares, as reported at the end of Q1 2023.